Patel M V, Roberts E F, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11616577 B2, 2020-09-03.
Thompson G K, Lee S K, Stevens L M. "Method for the Synthesis of N5-(3-((5-Acetamido-2-hydroxyphenyl)thio)-1-((carboxymethyl)amino)-1-oxopropan-2-yl)-L-glutamine" [P]. US Patent, US 9135982 B2, 2020-12-09.
发明人朱建伟,黄志刚,陈志强. "A Process for Preparing High-Purity N5-(3-((5-Acetamido-2-hydroxyphenyl)thio)-1-((carboxymethyl)amino)-1-oxopropan-2-yl)-L-glutamine" [P]. 中国发明专利, 专利号 CN 111920404 A, 授权公告日 2024-08-02.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2018, 2359, (1), 2847-2853.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2025, 2334, (6), 6960-6972.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of N5-(3-((5-Acetamido-2-hydroxyphenyl)thio)-1-((carboxymethyl)amino)-1-oxopropan-2-yl)-L-glutamine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 1079, (1), 6878-6894.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2022, 455, 7533-7541.